Early Phase Innovative Pediatric Oncology Program Achieves Successful First Multiple Solid Tumors Study
Early Phase Innovative Pediatric Oncology Program Achieves Successful First Multiple Solid Tumors Study
4 PagesCASE STUDY Early Phase Innovative Pediatric Oncology Program Achieves Successful First Multiple Solid Tumors StudyRegions North America : USA, Canada Western Europe: Austria, Denmark, France, Germany, Ireland, Italy, Netherlands, Spain, Switzerland, UK Middle East: Israel STUDY DESCRIPTION An early-phase, multicenter, open-label basket study of the study drug’s safety and pharmacokinetics in pediatric and young adult patients with previously treated solid tumors. Study Duration 5 years, 6 months (2014-2020) No. of Clinical Sites 2 consortia: POETIC, NA and ITCC, EU 35 Phase I (activated) 21 Phase II (not activated) Patient Population 115 patients screened 90 enrolled 87 treated Early Phase Innovative Pediatric Oncology Program Achieves Successful First Multiple Solid T
